EUVIMEDEUVIMED entdecken
Crossref

An evaluation of the genotoxicity and 90‐day repeated dose oral toxicity in rats of Porphyridium purpureum

Timothy S Murbach iD, Róbert Glávits, John R Endres, Gábor Hirka, Adél Vértesi, Erzsébet Béres, Ilona Pasics Szakonyiné

Journal of Applied Toxicology · 2024-10 · 44 (10) · 1616-1632

DOI: 10.1002/jat.4665 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Toxicology, 2024-07. Verfasst von Timothy S Murbach und 6 weiteren Autor:innen. Beteiligte Einrichtung: AIBMR Life Sciences, Inc., Seattle, Washington, USA. Hauptthemen laut MEDLINE: Micronucleus Tests, Mutagenicity Tests, Porphyridium, No-Observed-Adverse-Effect Level. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Queen Bioactives, Pty Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interest in microalgae products for use in food is increasing, as demands for sustainable and cost‐effective food choices grow due to the escalating global population and increase in climate‐related struggles with agriculture. Toxicological assessments of some species of microalgae have been conducted, but there were little data available for the oral consumption of the red microalgae Porphyridium purpureum and no data on genotoxicity. This article articulates a genotoxicity assessment and a 90‐day repeated dose oral toxicity study in rats performed according to OECD guidelines. Under the experimental conditions applied, the test item did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used in the bacterial reverse mutation test. Similarly, the test item did not induce structural chromosomal aberrations in V79 hamster lung cells. The test item also did not cause chromosomal damage in bone marrow of mice in the mammalian micronucleus test. The no observed adverse effect level (NOAEL) of the 90‐day repeated dose oral toxicity study in rats was determined to be the highest dose tested, 3000 mg/kg bw/day. These data add to the body of evidence regarding the safety of P. purpureum for human consumption.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Micronucleus TestsMutagenicity TestsPorphyridiumNo-Observed-Adverse-Effect LevelChromosome AberrationsAnimalsAdministration, OralMaleRatsFemaleCricetulusMiceCricetinaeDose-Response Relationship, DrugCell Line

Stichwörter der Autor:innen

NOAELPorphyridium purpureumclastogenicmicroalgaemutagenicsafetytoxicity

Autor:innen und Institutionen

  • AIBMR Life Sciences, Inc., Seattle, Washington, USA.
  • Toxi-Coop Zrt., Budapest, Hungary.
  • Toxi-Coop Zrt., Balatonfüred, Hungary.

ORCID-Profile: Timothy S Murbach

Förderung

  • Queen Bioactives, Pty Ltd

Zitieren

APA

Murbach, T. S., Glávits, R., Endres, J. R., Hirka, G., Vértesi, A., Béres, E., & Pasics Szakonyiné, I. (2024). An evaluation of the genotoxicity and 90‐day repeated dose oral toxicity in rats of Porphyridium purpureum. Journal of Applied Toxicology, 44(10), 1616-1632. https://doi.org/10.1002/jat.4665

Vancouver

Murbach TS, Glávits R, Endres JR, Hirka G, Vértesi A, Béres E, et al. An evaluation of the genotoxicity and 90‐day repeated dose oral toxicity in rats of Porphyridium purpureum. Journal of Applied Toxicology. 2024;44(10):1616-1632. doi:10.1002/jat.4665

BibTeX
@article{Murbach2024,
  author = {Murbach, Timothy S and Glávits, Róbert and Endres, John R and Hirka, Gábor and Vértesi, Adél and Béres, Erzsébet and Pasics Szakonyiné, Ilona},
  title = {An evaluation of the genotoxicity and 90‐day repeated dose oral toxicity in rats of Porphyridium purpureum},
  journal = {Journal of Applied Toxicology},
  year = {2024},
  volume = {44},
  number = {10},
  pages = {1616--1632},
  doi = {10.1002/jat.4665}
}
Kostenlos starten →